Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase pseudogene (ENSG00000227878, LOC100420572) refers to a non-functional genomic element homologous to the glutathione S-transferase family, notably associated with the GST theta-class gene cluster. The corresponding pseudogene has a splice site abnormality and a premature stop codon, preventing the production of a functional enzyme[3][4]. Unlike functional GST enzymes—which catalyze glutathione-dependent detoxification reactions—this pseudogene does not encode a protein, is not expressed, and lacks any known role in normal physiology or disease. It does not participate in cellular detoxification or serve any known therapeutic function. The information above applies specifically to glutathione S-transferase pseudogenes such as GSTT2P, and does not refer to active GST proteins, many of which are important in xenobiotic metabolism[1][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase pseudogene.